Economy

China central bank boosts liquidity injection through policy loan, rate unchanged













CARLOS DE SOUZA-UNSPLASH

SHANGHAI/SINGAPORE – China’s central bank ramped up liquidity injection but kept the interest rate unchanged when rolling over maturing medium-term policy loans on Wednesday, matching market expectations.

Market participants believe that a weakening Chinese yuan has constrained the central bank’s efforts to aggressively lower interest rates as the recovery of the world’s second-largest economy remains uneven and requires further stimulus.

The People’s Bank of China (PBOC) said it was keeping the rate on 1.45 trillion yuan ($199.92 billion) worth of one-year medium-term lending facility (MLF) loans CNMLF1YRRP=PBOC to some financial institutions unchanged at 2.50% from the previous operation.

The central bank said the loan operation was meant to maintain banking system liquidity reasonably ample to counteract short-term factors including tax payments and government bond issuance.

“At the same time, it will appropriately provide mid- and long-term base money,” the PBOC said in an online statement.

All 31 market watchers polled by Reuters this week expected the central bank to inject fresh funds to exceed the maturity.

“Weak inflation and the recent liquidity squeeze call for stronger policy support this week,” Carlos Casanova, senior economist for Asia at UBP, said in a note this week.

“Liquidity conditions tightened in October, as a deluge of bond issuance to fund fiscal stimulus and quarter-end cash demand from corporates drove up interbank rates. The most likely outcome is for PBOC to inject more support through open market operations, while leaving the MLF rate unchanged.”

He added that authorities will remain on alert and continue to support the recovery, expecting another 10-basis-point interest rate cut and an additional RRR cut in December, if not sooner.

The interest rate on one-year AAA-rated negotiable certificates of deposit (NCDs) AAANCD1Y=CFXS, which measure short-term inter-bank borrowing costs, is hovering at a six-month high of 2.5653%, about 7 bps higher than the MLF rate the central bank charges financial institutions.

With 850 billion yuan worth of MLF loans set to expire this month, the operation resulted a net 600 billion yuan fresh fund injection into the banking system.

Still, market watchers said the currency remained as a key constraint for the authorities to ease monetary policy. China’s yuan CNY=CFXS has lost about 5% to the dollar so far this year to become one of the worst performing Asian currencies.

The sizable depreciation has prompted authorities to step up efforts to support the currency, with many analysts believing policymakers may view yuan stability as a prerequisite for restoring confidence in yuan assets.CNY/

China remains an outlier among global central banks as it has loosened monetary policy to shore up a stalling recovery but further rate cuts will widen the yield gap with the United States, putting more pressure on the yuan and risking outflows.

The central bank also injected 495 billion yuan through seven-day reverse repos CN7DRRP=PBOC while keeping borrowing cost unchanged at 1.80%, it said in the statement. – Reuters

Jino Nicolas




Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

Disclaimer:

TheProficientInvestor.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 TheProficientInvestor. All Rights Reserved.

To Top